Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Travere Therapeutics to Present at Upcoming Investor Conferences By: Travere Therapeutics, Inc. via GlobeNewswire February 26, 2024 at 16:30 PM EST SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will participate in the following upcoming investor conferences in March: Cowen 44th Annual Health Care ConferenceMonday, March 4, 2024, at 9:10 a.m. ET Leerink Partners Global Biopharma ConferenceMonday, March 11, 2024, at 1:20 p.m. ET Barclays 26th Annual Global Healthcare ConferenceTuesday, March 12, 2024, at 2:05 p.m. ET Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations. Replays will be available for up to 30 days following each event. About Travere Therapeutics At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com. Contact Info Media:888-969-7879mediarelations@travere.comInvestors:888-969-7879IR@travere.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Travere Therapeutics to Present at Upcoming Investor Conferences By: Travere Therapeutics, Inc. via GlobeNewswire February 26, 2024 at 16:30 PM EST SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will participate in the following upcoming investor conferences in March: Cowen 44th Annual Health Care ConferenceMonday, March 4, 2024, at 9:10 a.m. ET Leerink Partners Global Biopharma ConferenceMonday, March 11, 2024, at 1:20 p.m. ET Barclays 26th Annual Global Healthcare ConferenceTuesday, March 12, 2024, at 2:05 p.m. ET Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations. Replays will be available for up to 30 days following each event. About Travere Therapeutics At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com. Contact Info Media:888-969-7879mediarelations@travere.comInvestors:888-969-7879IR@travere.com
SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will participate in the following upcoming investor conferences in March: Cowen 44th Annual Health Care ConferenceMonday, March 4, 2024, at 9:10 a.m. ET Leerink Partners Global Biopharma ConferenceMonday, March 11, 2024, at 1:20 p.m. ET Barclays 26th Annual Global Healthcare ConferenceTuesday, March 12, 2024, at 2:05 p.m. ET Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations. Replays will be available for up to 30 days following each event. About Travere Therapeutics At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com. Contact Info Media:888-969-7879mediarelations@travere.comInvestors:888-969-7879IR@travere.com